Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence

International Journal of Impotence Research

Volumn 10, Issue 2, 1998, Pages 113-120

  Moreland, R B ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

cAMP; Collagen; Corpus cavernosum; Erectile dysfunction; Hypoxemia; PGE1; TGF 1; Vascular smooth muscle

Indexed keywords

PROSTAGLANDIN E; TRANSFORMING GROWTH FACTOR BETA1;

CONNECTIVE TISSUE; CORPUS CAVERNOSUM; HUMAN; HYPOXEMIA; MALE; MOLECULAR BIOLOGY; NONHUMAN; PATHOLOGY; PENIS DISEASE; PENIS ERECTION; PENIS NOCTURNAL TUMESCENCE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE;

EID: 0031805037     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900328     Document Type: Review

References (56)

1. Kim N et al. Oxygen tension regulates the nitric oxide pathway: Physiological role in penile erection. j Clin Invest 1993; 91: 437-443.
2. Nehra A et al. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol 1996; 156: 1320-1329.
3. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin N Am 1995; 22: 699-709.
4. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
5. Munarriz RM et al. Blunt trauma: the pathophysiology of hemodynamic injury leading to erectile dysfunction. J Urol 1995; 153: 1831-1840.
6. Shafik A. Pudendal artery syndrome with erectile dysfunction: treatment by pudendal canal decompression. Arch Androl 1995; 34: 83-94.
7. Persson C et al. Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol 1989; 142: 1462-1468.
8. Jevtich M, Khawand NY, Vidic B. Clinical significance of ultrastructural findings in the corpus cavernosa of normal and impotent men. J Urol 1990; 143: 289-293.
9. Mersdorf A et al. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients J Urol 1991; 145: 749-758.
10. Wespes E et al. Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol 1991; 146: 1015-1017.
11. Luangkhot R et al. Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol 1992; 148: 467-471.
12. Hatzichristou DG et al. In vivo assessment of trabecular smooth muscle tone, it's application in pharmacocavernosometry and analysis of intracavernosal pressure determinants. J Urol 1995; 153: 1126-1131.
13. Andersson K-E, Wagner G. Physiology of erection. Physiol Rev 1995; 75: 191-236.
14. 1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826-834.
15. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.
16. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Inv 1992; 90: 1-7.
17. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med 1994; 331: 1286-1291.
18. Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol 1987; 105: 465-471.
19. 1 is mediated by collagen. J Biol Chem 1989; 264: 18069-18077.
20. Nabel EG et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993; 90: 10759-10763.
21. 1 expression and PGE production in human corpus cavernosum smooth muscle cells. Mol Urol 1998; 2: 41-47.
22. 1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells. Int J Imp Res 1998, in press.
23. Massague J, Attisano L, Wrana JL. The TGF-β family and its composite receptors. Trends in Cell Biol 1994; 4: 172-178.
24. Goodman LV, Majack RA. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density. J Biol Chem 1989; 264: 5241-5244.
25. Baum BJ et al. Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. J Biol Chem 1980; 255: 2843-2847.
26. 2 on transforming growth factor-β and insulin-induced collagen formation in lung fibroblasts. J Biol Chem 1989; 264: 16988-16991.
27. 2 and to express cyclooxygenase-2. J Clin Inv 1995; 95: 1861-1868.
28. Conary JT et al. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J Clin Inv 1994; 93: 1834-1840.
29. Roy AC, Tan SM, Kottegoda SR, Ratnam SS. Ability of human corpus cavernosum to generate prostaglandins and thromboxanes in vitro. IRCS Med Sci 1984; 12: 608.
30. Daley JT et al. Prostanoid production in rabbit corpus cavernosum I. Regulation by oxygen tension. J Urol 1996; 155: 1482-1487.
31. Azadzoi KM, Siroky MB, Goldstein I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996; 155: 1795-1800.
32. Kim JH et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994; 151: 198-205.
33. Azadzoi KM et al. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997; 157: 1011-1017.
34. Nehra A et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998, in press.
35. 1 mediated cavernosal fibrosis is modulated by econsanoids. Int J Imp Res 1996; 8: 108 (Abstract A36).
36. Azadzoi KM, Saenz de Tejada I. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1992; 148: 1587-1591.
37. Gupta S et al. Diabetes-induced structural changes in rabbit corpus cavernosum. Int J Imp Res 1996; 8: 136 (Abstract D55).
38. 1 induced corporal fibrosis: implications for penile ischemiaassisted fibrosis. J Urol 1996; 155: 622A (Abstract 1243).
39. Mills TM, Reilly CM, Lewis RW. Androgens and penile erection: a review. J Androl 1996; 17: 633-638.
40. Buena F et al. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 1995; 59: 1118-1123.
41. Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypergonadism: double blind placebo-controlled trial with clomiphene citrate. Clin Endocrinol Metab 1995; 80: 3546-3552.
42. Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997; 157: 849-854.
43. Penson DF et al. Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 1996; 55: 567-574.
44. Schirar A, Chang C, Rousseau JP. Localization of androgen receptor in nitric oxide synthase- and vasoactive intestinal peptide-containing neurons of the major pelvic ganglion innervating the rat penis. J Neuroendocrinol 1997; 9: 141-150.
45. Carrier S et al. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol 1997; 157: 1088-1092.
46. Burnett AL et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 1996; 2: 288-296.
47. Halverson HM. Genital and sphincter behavior of the male infant. J Gen Psychol 1940; 56: 95.
48. Shirozu H et al. Penile tumescence in the human fetus at term - a preliminary report. Early Hum Dev 1995; 41: 159-166.
49. Fischer C, Gross J, Zuch J. Cycle of penile erections synchronous with dreaming (REM) sleep: preliminary report. Arch Gen Psychiatry 1965; 12: 29-45.
50. Schiavi RC et al. Hormones and nocturnal penile tumescence in healthy aging men. Arch Sex Behav 1993; 22: 207-215.
51. Hirshkowitz M et al. Prevalence of sleep apnea in men with erectile dysfunction. Urology 1990; 36: 232-234.
52. Karacan I. Erectile dysfunction in narcoleptic patients. Sleep 1986; 9: 227-231.
53. Guldner GT, Morrell MJ. Nocturnal penile tumescence and rigidity evaluation in men with epilepsy. Epilepsia 1996; 37: 1211-1214.
54. Karacan I, Karatas M. Erectile dysfunction in sleep apnea and response to CPAP. J Sex and Marital Therapy 1995; 21: 239-247.
55. Montorsi F et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of Alprostadil: Results of a prospective randomized trial. J Urol 1997; 158: 1408-1410.
56. Basile G et al. Can self-injection therapy "cure" impotence? In: Goldstein I and Lue TF, eds. The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction. Excerpta Medica: Princeton, 1993, pp 109-116.